Previous Close | 5.0900 |
Open | 5.1500 |
Bid | 4.7700 x 1000 |
Ask | 4.9700 x 1100 |
Day's Range | 4.8700 - 5.1600 |
52 Week Range | 4.2400 - 6.5500 |
Volume | |
Avg. Volume | 301,247 |
Market Cap | 158.48M |
Beta (5Y Monthly) | 1.26 |
PE Ratio (TTM) | 11.63 |
EPS (TTM) | 0.4300 |
Earnings Date | Mar 29, 2022 - Apr 04, 2022 |
Forward Dividend & Yield | 0.48 (10.69%) |
Ex-Dividend Date | Apr 08, 2022 |
1y Target Est | 6.75 |
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th \- 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Spring into Action: VIRTUAL begins on Monday, May 16th, 2022, with a Biotech Discovery Day.
BRANFORD, CT / ACCESSWIRE / May 12, 2022 / Sachem Capital Corp. ("Sachem Corp" or the "Company") (NYSE American:SACH), today announced that Bill Haydon, Chief Investment Officer and Director of Sachem, has been invited to present at the Spring Into Action - Best Ideas Investor Conference, which is being held virtually on May 16th - 20th, 2022.
BRANFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) announces the closing of its previously announced registered public offering of $27.5 million aggregate principal amount of 7.125% unsecured, unsubordinated notes due 2027 (“Notes”). The net proceeds of the offering are estimated to be approximately $26.3 million after payment of underwriting discounts and commissions and estimated offering expenses payable by the company. Sachem has granted the underwri